www.fdanews.com/articles/159313-miraculins-signs-letter-of-intent-with-beijing-based-cachet-pharmaceutical

Miraculins Signs Letter of Intent With Beijing-Based Cachet Pharmaceutical

October 1, 2013

Miraculins announces the execution of a non-binding letter of intent with Cachet Pharmaceutical, a $654 million wholesale/retail drug distribution and medical device distributor, with over $408 million in annual sales.
FirstWord MedTech